Prospectus Exposure - LAC Med Berhad

The prospectuses published here have not been registered with the SC under Section 232 of the Capital Markets and Services Act 2007 and is solely for the purpose of seeking comments from the public. THESE PROSPECTUSES SHOULD NOT BE USED FOR MAKING ANY INVESTMENT DECISION. Securities cannot be offered and application for securities cannot be accepted until the prospectus has been registered by the SC.

The SC shall not be liable for any non-disclosure on the part of the corporation and takes no responsibility for the contents of the prospectuses, makes no representation as to its accuracy or completeness and expressly disclaims any liability for any loss suffered arising from or in reliance upon the whole or any part of the contents of the prospectuses published here.

Details of prospectus

Company Name	:	LAC Med Berhad ("LAC'')
Proposal Type and Board	:	Initial Public Offering on the Main Market
Principal Adviser(s)	:	RHB Investment Bank Berhad
Principal Activity	:	LAC and its subsidiaries are principally involved in the supply and integration of medical devices, and related products and services as well as provision of information and communication technology products and services for healthcare facilities.
Shares to be issued/offered	:	Initial public offering of up to 124,197,600 ordinary shares in LAC ("Shares") in conjunction with the listing of and quotation for the entire enlarged issued share capital of LAC on the Main Market of Bursa Malaysia Securities Berhad comprising: Public issue of 74,197,600 new Shares ("Issue Shares") in the following manner: 20,000,000 Issue Shares for application by the Malaysian public; 4,197,600 Issue Shares for application by the eligible directors, employees and persons who have contributed to the success of LAC and its subsidiaries; and 50,000,000 Issue Shares by way of private placement to Bumiputera investors approved by the Ministry of Investment, Trade and Industry of Malaysia; and Offer for sale of up to 50,000,000 existing Shares by way of private placement to institutional and selected investors, subject to the clawback and reallocation provisions.
Date of Exposure	:	5 June 2025

Download prospectus in separate files

Cover Indicative Timetable Table of Contents Presentation of Information Forward-Looking Statements Definitions Glossary of Technical Terms	(pdf - 309KB)
Corporate Directory	(pdf - 82KB)
Prospectus Summary	(pdf - 224KB)
Approvals and Conditions	(pdf - 69KB)
Details of Our IPO	(pdf - 164KB)
Information on Our Promoter, Substantial Shareholders, Directors and Key Senior Management	(pdf - 997KB)
Information on Our Group	(pdf - 153KB)
Business Overview	(pdf - 1.12MB)
Industry Overview	(pdf - 220KB)
Risk Factors	(pdf - 113KB)
Related Party Transactions	(pdf - 88KB)
Conflict of Interest	(pdf - 76KB)
Financial Information	(pdf - 722KB)
Accountants' Report	(pdf - 853KB)
Additional Information	(pdf - 106KB)
Summarised Procedures for Application and Acceptance	(pdf - 118KB)

Download prospectus in single file: pdf - 5.57MB

COMMENT